Pa ge 1 Pa ge 8 American Journal of Chemistry and Pharmacy (AJCP) Seroma Formation after Mastectomy with or without Thoracoabdominal Binder – A Randomized Control Trial Maryam Essa Alfard1*, Shereya Devendra2 Volume 2 Issue 2, Year 2022 ISSN: 2834-0116 (Online) DOI: https://doi.org/10.54536/ajcp.v2i2.1540 https://journals.e-palli.com/home/index.php/ajcp Article Information ABSTRACT Received: April 10, 2023 Accepted: May 01, 2023 Published: May 16, 2023 The study’s main objective is to reduce seroma production post-mastectomy with the help of using thoracoabdominal binders. The randomized controlled trial (RCT) included patients (No=40) that received breast surgery. They were divided into two groups; the control group (No=20) was the one that did Not use the binders, and the study group (No=20), complied with adorning the thoracoabdominal binder for two weeks post-breast surgery. The drainage of both breasts and axillary drains was examined during this duration. The amount of drainage was Noted, and charts were created on that basis. A total of 40 patients initially became a part of this trial, equally divided into two groups of 20 patients each. All of the participants of this group had undergone breast surgery (either mastectomy or MRM) and had to appear for the follow-up examination 2-3 weeks post-surgery. In these follow-up meetings in the outpatient clinic, the drainage charts were maintained, including the levels of drain output and compliance rate of the thoracoabdominal binder group; some patients were excluded from the study due to exclusion criteria.There was No difference between both groups in the drainage output, thus imposing No major impact of thoracoabdominal binders on seroma reduction. Other implications of binders in breast care post-surgery were explored to add to the positive effects of binders. This suggests that more studies need to be done to find the best management methods for postoperative seroma formation. Keywords Breast Care, Drainage, Mastectomy, Seroma, Thoracoabdominal Binders 1 Specialized Surgeon, Dubai Hospital, United Arab Emirates 2 222, Al Khaleej St - Deira, Dubai, United Arab Emirates * Corresponding author’s e-mail: maryamessa23alfard@outlook.com INTRODUCTION Breast cancer these Days addresses the most widely recognized cancer among ladies, with more than 2 million new cases in 2018. Its careful treatment depends on oncoplastic medical procedure, a combination of those two disciplines with the last objective of a result adjusted between the best oncologic and therapeutic outcomes. Without a doubt, since its origination, breast remaking has assisted patients with looking “typical” when dressed; all the more, as of late, progressions in careful procedures and clinical advancements have increased present expectations so patients can feel tastefully satisfied and likewise unclothed (Salgarello, 2012). During the many previous years, the straightforward way to deal with breast cancer has developed from extremist mastectomy to the improvement of breast‐conserving medical procedures and reconstructive strategies. After an areola or skin‐ sparing mastectomy, the chance of having played out a prompt remaking addresses an extraordinary benefit for patients, inferable from its critical psychosocial benefits. As of Now, quick implant‐based breast remaking (IBR) addresses 81.9% of all breast reconstructive strategies (Masià et al., 2020). Axillary lymphadenectomy (ALN) remains the standard choice in many cases of breast tumors. Likewise, to agony, hematoma and contamination, the fundamental early unfavorable impact of ALN is the post-usable creation of liquid in the axillary bowl. Seroma development is a consistent component; however, the volume has a wide variety. Subsequently, the pace of symptomatic seromas that require needle yearning goes from 20 to 60% (Kopelman et al., 1999). Seroma is defined as the clear fluid deposited under the primary layer of the skin, which is usually found near the incision site after surgery, typically of reconstructive type (Pogson et al., 2003). This occurs because space is created in such surgical procedures due to tissue removal. Seroma is a typical post-surgery complication in breast cancer. It is considered a common cause of discomfort and irritation in patients, which might result in extending the hospital stay. It can cause problems like an infection on the site of surgery, slow laceration healing, and mortification of the skin flap. Substantial research is being carried out to comprehend the etiology to uncover different means of reduction of seroma formation (de Rooij et al., 2020). LITERATURE REVIEW Countless RCTs are being established to reduce complications created by seroma formation. Many studies give a mixed opinion over the insertion of drainage post- surgery as a method of seroma reduction. Florian et al. (Ebner et al., 2014) explain that the most common reasons for the introduction of a drain in breast cancer surgery are: (i) reducing the risk of a possible hematoma, (ii) drainage of the seroma of the incision, or (iii) controlling the infections occurring at the surgical site. It has also been stated that Not including a drain might have the following side effects: a larger amount of seroma-related complications. Other risk factors like the size of the breasts, age, number of lymph Nodes with tumors and blood pressure have also been examined in the past years (Droeser et al., 2009; Srivastava et al., 2012). https://doi.org/10.54536/ajcp.v2i2.1540 https://journals.e-palli.com/home/index.php/ajcp mailto:maryamessa23alfard@outlook.com Pa ge 9 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 Drain Using a drain has been a typical practice to demolish the dead space made after a medical procedure. The utilization of closed suction drainage in patients who went through mastectomy speeds up injury recuperating and is likewise connected with a lower occurrence of wound contamination, necrosis, and breakdown (Srivastava et al., 2012). Research by Bourke et al (Bourke et al., 1976) found No distinction between utilizing closed suction and creased wound drainage in 51 patients who underwent straightforward mastectomy (Thoren, 1964). In a concentrate by Whitfield and Rainsbury (Whitfield & Rainsbury, 1994), No huge contrast was seen between suctioned and closed siphon drainage on seroma development. The amount of quantity of drain tubes used has been researched. Two randomized trials reported that using different drainage tubes presents No critical benefit on the sum or length of seroma seepage (Petrek et al., 1992; Terrell & Singer, 1992). Thoracoabdominal Binders A thoracoabdominal binder is a wide belt encompassing the thorax and abdomen and supporting the incision. Binders have been around for quite a while, yet their significance has fluctuated over the long run; there has forever been disagreement concerning whether they were great for patients or useless. Accordingly, we led the current randomized controlled trial to explore the clinical impacts of thoracoabdominal binders. We plan to give proof- based ideas to its expected in postoperative consideration for breast surgeries (Jiang et al., 2021). Stomach versatile folios (trusses, girdles, stomach belts, longuette, and so forth) (Cheifetz et al., 2010; Fagevik Olsén et al., 2009; Christopher M Larson et al., 2009) are often utilized regularly after laparotomy and ventral hernia fix. The beneficial impacts incorporate, among others, relief from discomfort, decreased chance of seroma development, worked on respiratory capability and postural strength. In any case, using abdominal binders depends on unclear or No proof. Besides, the clinical impacts of stomach covers have been tested because of an expected gamble of post- usable pneumonic inconveniences (Rothman et al., 1966). On the positive side, documentation from a couple of studies infers that stomach fasteners reduce postoperative torment, seroma development, mental distress, and postoperative uneasiness (P. Chowbey et al., 2000; Jin et al., 2009; Christopher M Larson et al., 2009; K. LeBlanc, 2004). Abdominal binders have likewise been shown to upgrade activation, safeguard the patient’s injury, help in coughing, and ease deep breathing (Rothman et al., 1966). Lymphedema is a well-kNown condition occurring right after breast surgery, but No agreement has been reached about the best treatment course. Careful methodologies, despite, are getting expanded consideration. Different microsurgical reconstructive procedures plan to reestablish life structures and capability of the lymphatic framework in upper limb breast cancer-related lymphedema (BCRL) (Masia et al., 2016). Since the lymphatic system is a complex vascular system, we concentrate on its life systems and usefulness in every individual patient utilizing symptomatic imaging strategies: lymphoscintigraphy, figured tomography angiography (CTA), indocyanine green (ICG) backhanded lymphography, and magnetic resonance (MR)- lymphography. A preoperative limb lymphoscintigraphy is performed for every patient to evaluate the lymphatic capability of the limb. MATERIALS & METHODS Study Design This is a Randomized Controlled Trial (RCT) based on exploring the effectiveness of using thoracoabdominal binders in seroma reduction post-mastectomy. The Dubai Hospital Ethical Committee examined and approved the study procedure. All participants provided their consent in writing after being fully informed. The participants’ privacy was protected throughout the study, and the confidentiality of the data acquired was guaranteed.The patients who consented to participate in this study were allotted to one of the two groups: the thoracoabdominal group, where patients adorned binders post-surgery. At the same time, the other was the control group (without binders). Both groups were carefully observed to compare the seroma drainage amount and other complications (if any). Setting and Patient Selection Patients were selected from three different Saudia Arabia regions: central, Northern and southern. Patients who had received breast surgeries such as mastectomy or modified radical mastectomy (MRM) because of invasive breast cancer or ductal carciNoma in situ (DCIS) were qualified for consideration in the present trial. Patients undergoing a breast-enlargement procedure or primary breast reconstructive treatments were barred. Interim Analysis The interim analysis for this seroma reduction after MRM or mastectomy trial was initially conducted to identify the effectiveness of thoracoabdominal binders. None of the postoperative methods seemed superior to discontinuing the rest of the practice at that particular interval. Randomization According to a PC-created randomization plan, patients will be arbitrarily allocated to one of the two bunches with a 1:1 distribution. Randomization will occur upon the arrival of the medical procedure, half an hour preceding incision closure. Blinding Blinding of the procedure was impossible as the patients were physically wearing thoracoabdominal binders, and they could Not hide the main element of the study to make the trial Non-biased. Pre-op Medications Patients were given Kefzol (antibiotic) once before the https://journals.e-palli.com/home/index.php/ajcp Pa ge 10 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 surgical procedure. These medications were administered to reduce the Surgical Site Infections (SSI) rate. Surgical Site Infections (SSI) influence the oncologic consideration of breast cancer patients because of postpones in different Treatments, expansions in care expenses, failed recreations, and possibly development in recurring disease rates. The rate of surgical site infections has decisively increased in literature as per the reported cases. The increment range is dramatic as if it skyrocketed from 0.8% to being raised to 26% (Edwards et al., 2009; Neumayer et al., 2007; Prospero et al., 2006). Surgical Procedure In simple mastectomy, the whole breast tissue is eliminated; axillary tissues are undisturbed. At times, the “sentinel lymph Node” — the central axillary lymph Node that the metastasizing cancer cells would be supposed to deplete into — is taken out. Individuals who go through a simple mastectomy can typically leave the clinic after a brief stay. Regularly, a drainage tube is embedded during a medical procedure in their chest and joined to a little suction device to eliminate subcutaneous liquid. These are Normally eliminated a few Days after the medical practice as drainage declines to less than 20-30 ml daily. When this procedure is completed on a tumourous breast, it is also performed on a healthy breast to prevent cancer recurrence. The decision of this “contralateral prophylactic” choice has become more run of the mill as of late in California, most outstanding in individuals more youthful than 40, moving from only 4% to 33% from 1998 to 2011. Nonetheless, the potential advantages give off an impression of being negligible, best case scenario, without any genetic markers, as per a huge scope study distributed in 2014 (Kurian et al., 2014; Newman, 2014; Tanner, 2014). Customary Incision Closure The incision was then closed using conventional, absorbable skin sutures, and None of the modern skin flaps were utilized after the mastectomy. Medications after Surgery Most patients were given 500mg of Kefzol every six hours for two weeks. Some patients were advised to use Kefzol only once for seven Days, and only a few were given Augmentin for 7 Days. Hospital Stay The patients have been advised of the duration of their hospital stay as per their post-op condition. Some were even kept in the hospital for about ten Days. Post-op Complications Several complications occur post-mastectomy or MRM, including lymphedema, shoulder morbidity and seroma aspiration. The one we encountered during this RCT was a hematoma. Hematoma is a pool of mostly coagulated blood that structures in an organ, tissue, or body space. A hematoma is typically brought about by a messed up vein that was harmed by a medical procedure or a physical injury (Hematoma, toenail, gross, 2013). It can accumulate at any place in the body, including the brain. Not at all like cancer, breast hematomas are mostly harmless. Treatment of a hematoma relies upon its seriousness. Small hematomas might resorb following a couple of Days. More extreme hematomas that keep expanding might expect a medical procedure to deplete the gathered blood or potentially control any draining vessels and reclose the surgical site (Hoda & Cheng, 2017). Follow up The patients were told to show up for the follow-up 2-3 weeks before mastectomy or MRM. Evaluation The assessment was tentatively directed in the two groups, with the same philosophy and absence of pain convention. The principal factors explored were seroma production, pain before and after the medical procedure, post-op complications, the number of Days the drain was attached, etc. Symptomatic seroma was characterized as an axillary liquid collection initiating inconvenience or pain with clinical consultation. Exclusion Criteria The exclusion criteria were based on the following points: (1) Patients unwilling to share their details publicly. (2) Patients who were unable to comprehend the reason behind the study and its extent and, for that reason, Table 1: Basic history collection of the trial. N o. C on tr ol / tr ea tm en t M R N G en de r A ge N at io na lit y R eg io n T yp e of s ur ge ry M ed ic al H is to ry 1 Pr ev io us S ur ge ry at th e Sa m e Si te T yp e of C an ce r B lo od L os s N eo ad ju va nt C he m ot he ra py T um ou r S iz e 1 C on tro l 51 19 06 7 Fe m al e 30 -3 9 Sa ud i C en tra l M RM FI BR O C Y ST IC D IS E A SE N o ID C < 50 m l Ye s 2- 5 cm https://journals.e-palli.com/home/index.php/ajcp Pa ge 11 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 2 C on tro l 51 24 13 9 Fe m al e 30 -3 9 Sa ud i C en tra l M RM O be sit y N o ID C < 50 m l Ye s < 2 cm 3 C on tro l 51 34 04 6 Fe m al e 60 -6 9 Sa ud i C en tra l M RM H TN , O LF C VA , C K D , A N E M IA N o ID C 50 -1 00 m l N o 2- 5 cm 4 C on tro l 51 26 83 6 Fe m al e 50 -5 9 Sa ud i C en tra l M as te ct om y Po st m eN op au sa l N o ID C + D C IS < 50 m l N o > 5 cm 5 C on tro l 51 15 88 7 Fe m al e 40 -4 9 Sa ud i C en tra l M RM 0 N o ID C < 50 m l Ye s > 5 cm 6 C on tro l 51 21 76 5 Fe m al e 40 -4 9 Sa ud i C en tra l M RM D M , H TN N o IL C G ra de 2, E RP R+ , H E R2 - < 50 m l Ye s > 5 cm 7 C on tro l 51 17 08 0 Fe m al e 60 -6 9 Sa ud i N or th M RM D M N o ID C < 50 m l Ye s > 5 cm 8 C on tro l 51 19 00 7 Fe m al e 50 -5 9 Sa ud i N or th M RM D M , B A N o ID C 50 -1 00 m l Ye s > 5 cm 9 C on tro l 51 22 17 7 Fe m al e 50 -5 9 Sa ud i N or th M RM D M , H TN N o ID C > 10 0 m l Ye s > 5 cm 10 C on tro l 51 15 11 9 Fe m al e 40 -4 9 Sa ud i C en tra l M as te ct om y H TN , E SR D N o ID C < 50 m l Ye s 2- 5 cm 11 C on tro l 94 94 54 Fe m al e 40 -4 9 O th er C en tra l M RM 0 N o ID C < 50 m l Ye s 2- 5 cm 12 C on tro l 83 25 01 Fe m al e 50 -5 9 Sa ud i C en tra l M as te ct om y D M , H TN Ye s D C IS < 50 m l Ye s+ ra di at io n < 2 cm 13 C on tro l 51 21 97 1 Fe m al e 50 -5 9 Sa ud i C en tra l M as te ct om y 0 N o ID C R ig ht Br ea st < 50 m l N o 2- 5 cm 14 Tr ea tm en t 51 30 88 8 Fe m al e 50 -5 9 Sa ud i C en tra l M RM 0 N o ID C < 50 m l N o > 5 cm https://journals.e-palli.com/home/index.php/ajcp Pa ge 12 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 15 Tr ea tm en t 51 12 13 0 Fe m al e 50 -5 9 Sa ud i C en tra l M RM D M , H TN , FA M IL Y H IS TO RY O F U TE RI N E C A RC IN oM A N o Po or ly D iff er en tia te d C ar ci N om a 50 -1 00 m l Ye s > 5 cm 16 Tr ea tm en t 51 24 09 1 Fe m al e 50 -5 9 Sa ud i So ut h M RM BA N o ID C G ra de 3 < 50 m l Ye s 2- 5 cm 17 Tr ea tm en t 51 17 94 8 Fe m al e 50 -5 9 Sa ud i N or th M as te ct om y 0 N o ID C G ra de 3 < 50 m l Ye s 2- 5 cm 18 Tr ea tm en t 50 22 25 7 Fe m al e 30 -3 9 Sa ud i C en tra l M RM 0 N o H yp er pl as ia A ty pi ca l W IT H IC D < 50 m l N o 2- 5 cm 19 Tr ea tm en t 51 30 82 0 Fe m al e 40 -4 9 Sa ud i N or th M as te ct om y 0 Ye s ID C G ra de 1 < 50 m l N o 2- 5 cm 20 Tr ea tm en t 48 01 30 Fe m al e 30 -3 9 Sa ud i C en tra l M RM O st eo sa rc om a Ri gh t F em ur , LE FT B RE A ST C A N C E R N o ID C 50 -1 00 m l Ye s 2- 5 cm 21 Tr ea tm en t 99 54 56 Fe m al e 70 -7 9 Sa ud i ce nt ra l M as te ct om y D M , H TN , LE FT BR E A ST C A N C E R, B A N o D C IS < 50 m l N o < 2c m 22 Tr ea tm en t 41 43 5 Fe m al e 70 -7 9 Sa ud i N or th M RM D M , H TN N o ID C < 50 m l Ye s 2- 5 cm 23 Tr ea tm en t 51 24 61 5 Fe m al e 50 -5 9 Sa ud i ce nt ra l M as te ct om y D M , H TN N o ID C < 50 m l Ye s < 2c m 24 Tr ea tm en t 51 23 21 8 Fe m al e 40 -4 9 ot he r C en tra l M RM 0 N o ID C < 50 m l Ye s 2- 5 cm 25 Tr ea tm en t 51 20 82 4 Fe m al e 50 -5 9 Sa ud i C en tra l M RM 0 N o ID C < 50 m l Ye s 2- 5 cm https://journals.e-palli.com/home/index.php/ajcp Pa ge 13 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 Table 2: Data of drain collection and post-op condition. N o. M et s to L N s Antibiotics Coverage H ei gh t W ei gh t B M I D ra in 1 D ra in 2 R em ov al o f D ra in o n Po st -O p D ay N o. Ph ys io th er ap y E xe rc is es Pa tie nt C om pl ia nc e w ith W ea rin g th e B el t Po st -o p co m pl ic at io ns 1 N1 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 17 5 79 .3 25 .9 111ml TO 5ml 120ml TO 25ml D ay 1 4 Ye s C on tro l G ro up N o 2 N0 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 16 3 89 .6 33 .7 200ml TO 20ml 130ml TO 10ml D ay 1 4 Ye s C on tro l G ro up N o 3 N2 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 14 8. 5 72 .9 33 160ml TO 30ml 130ml TO 10ml D ay 1 4 Ye s C on tro l G ro up N o 4 N0 Kefzol Once Pre-Op, Post- Op Augmentin 7 Days 16 4 62 .7 23 .3 132ml TO 20ml 0 D ay 9 N ot n ee de d C on tro l G ro up N o 5 N2 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 15 0 97 .1 43 .2 210ml TO 10 ml 115ml TO 10ml D ay 3 3 Ye s C on tro l G ro up N o 6 N2 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 15 8 87 .3 35 150ml TO 65 ml 100ml TO 10ml D ay 1 8 Ye s C on tro l G ro up N o 7 N2 Kefzol Once Pre-Op 15 0 54 .4 24 .2 167ml TO 15ml 110ml TO 5ml D ay 1 4 Ye s C on tro l G ro up N o 8 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 16 6 85 .5 31 140ml TO 23ml 120ml TO 5ml D ay 1 4 Ye s C on tro l G ro up N o https://journals.e-palli.com/home/index.php/ajcp Pa ge 14 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 9 N3 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 15 9 67 .5 26 .7 150ml TO 30ml 120ml TO 10ml D ay 1 4 Ye s C on tro l G ro up H em at om a Po st -O p D ay 3 10 N0 Kefzol Once Pre-Op 16 4 76 .9 28 .6 100ml TO 5ml 0 D ay 10 N ot n ee de d C on tro l G ro up N o 11 N1 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 15 5 69 .7 29 150ml TO 40ml 110ml TO 10ml D ay 1 4 Ye s C on tro l G ro up N o 12 N0 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 15 5 64 26 .6 170ml TO 10ml 0 D ay 1 4 N ot n ee de d C on tro l G ro up N o 13 N0 Kefzol Once Pre-Op and Post-Op for 7 Days 15 6 56 23 .7 130ml TO 10ml 0 D ay 1 4 N ot n ee de d C on tro l G ro up N o 14 N1 Kefzol Once Pre-Op and Post-Op for 7 Days 15 3 76 .9 32 .9 140ml TO 10ml 124ml TO 5ml D ay 9 Ye s Ye s N o 15 N3 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 16 4 82 .1 30 .5 122 ml TO 10ml 120ml TO 5ml D ay 1 4 Ye s Ye s N o 16 N1 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 16 8 73 25 .9 220ml TO 10ml 160ml TO 5ml D ay 1 4 Ye s Ye s N o 17 N1 Kefzol Once Pre-Op, Post- Op Augmentin 7 Days 15 8 71 .4 28 .6 150ml TO 30ml 0 D ay 1 4 N ot n ee de d N o N o https://journals.e-palli.com/home/index.php/ajcp Pa ge 15 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 18 N1 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 15 0 58 .4 26 120ml TO 20ml 50ml TO 5 ml D ay 1 4 Ye s Ye s N o 19 N0 Kefzol Once Pre-Op and Post-Op for 7 Days 16 0 86 .6 34 .5 190ml TO 10ml 0 D ay 1 4 N ot n ee de d Ye s N o 20 N3 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 16 3 90 53 200ml TO 10ml 170ml TO 10ml D ay 1 4 Ye s Ye s N o 21 N0 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 15 6 73 .2 30 .1 150ml TO 15ml 0 D ay 1 4 N ot n ee de d Ye s N o 22 N1 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 14 2. 5 77 .2 38 144 ml TO 10ml 110ml TO 10ml D ay 1 4 Ye s Ye s N o 23 N0 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 14 7 80 .4 37 .2 110 to 5ml 0 D ay 1 4 N ot n ee de d Ye s N o 24 N1 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 15 8 72 28 .8 130ml TO 20ml 120ml TO 5ml D ay 1 4 Ye s Ye s N o 25 N1 Kefzol Once Pre-Op, Keflex 500 Mg q6hrs 2 Weeks 16 2 70 .7 26 .9 110ml TO 25ml 150ml TO 10ml D ay 1 4 Ye s Ye s N o did Not sign the consent form. (3) Patients who never showed up for a follow-up. (4) Those whose drainage charts were Not managed were also excluded. RESULTS AND DISCUSSION As per the research, no recognizable difference was found in the group of patients wearing the thoracoabdominal binders compared to the patients not wearing the binder in the quantity of seroma production. Statistical Analysis When the values of the drain removal of the control group (G1) and treatment group (G2) are compared statistically, the standard deviation of Drain 1 of the control group (s=16.753) and that of the treatment group (s=7.5252) vary greatly as it gives us the p-value of 0.01249. This shows a distinguishable difference, but the SD values of Drain 2 (G1= 6.95 & G2 = 3.964) did not show a distinct difference with the p-value of 0.07272, implementing the non-significant difference in the SD of both groups. This https://journals.e-palli.com/home/index.php/ajcp Pa ge 16 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 nullifies the difference in the first drain and thus brings us back to the conclusion that there was no remarkable difference in the seroma production of the binder and non-binder groups. (All the calculations were performed using SPSS (IBM SPSS Statistics for Windows, version 25, New York, USA). Primary Outcome The quantity of drain extracted the first time ranged from 5ml to 65ml in the control group, while in the treatment group, the range was from 5ml to 30 ml. In the second drain removal, the field dropped from 0ml to 25ml in the control group, while the treatment group’s range fell from 0ml to 10ml (Table No.2). However, since only 25 patients were left for the conclusive results, the result’s significance declined. Also, the statistical analysis suggests otherwise. The sizes of the tumors extracted (Table No. 1), BMI, body weight (Table no. 2) etc., are also mentioned in the tables. The size of the tumor barely affects seroma production, but the increased body weight and BMI may increase the levels of seroma production (Srivastava et al., 2012). Secondary Outcomes Although there was no major difference in the seroma production of the patients undergoing mastectomy or MRM, many other positive changes were detected in this RCT. Pain Binders worked as a pain-relief mechanism as they applied enough pressure on the thoracoabdominal region to relieve the patients of postoperative pain after the surgery. In another study (Daniel & Matheson, 1969), it was also evident that abdominal binders acted as pain- relieving equipment. It was a short study following in a logical order, where patients were their control group (n=16). This study was conducted on patients who had to undergo major abdominal surgeries and wore binders for only about 10 minutes. The patients brought to attention that they felt a minor difference in the feeling of pain while wearing the binder. They felt less pain than those without the abdominal binder. Pulmonary Stress The patient reported that the stress in breathing was significantly reduced for those wearing the binders compared to those not. To support this statement, one RCT (C. M. Larson et al., 2009) (n=23) reported the aid of abdominal binders in the pulmonary function stating that the vital capacity of the lungs increased recognizably in the binder group compared to the control group. Physical Activity As it is common knowledge, shoulder immobility is also frequent post-breast surgery. The patients wearing a binder showed less discomfort while moving their hands than the non-binder group. Still, the hand movement remained restricted. An approach supported by most breast surgeons is to suggest that patients limit signs at the shoulder to move away from the midline to no more prominent than 90 and that active upper extremity physiotherapy is postponed until drainage catheters have been eliminated (Vitug & Newman, 2007). Also, a study (Rothman et al., 1966) suggested that abdominal binders greatly help with the patient’s physical functions. (Where physical function means a six-minute walk) (n=75). The two groups were examined for the distance they walked in the given time before the surgery and five days following the surgery. It was concluded that the binder group walked a significantly longer distance on day 5 than the non-binder group, which supports our statement claiming improvement in hand and shoulder movement post-surgery with the help of a thoracoabdominal binder. Nevertheless, still, the results are ambiguous when compared to other research. It is safe to say that binders may help in improving physical function. Still, more studies need to implement thoracoabdominal binders as safe and beneficial post-op care equipment. Discomfort Discomfort is one of the main reasons many patients disagree with using a binder. The feeling of uneasiness and constantly being compressed may be a difficulty most people do not want to endure. The pressure binder applied to the incision site may be uncomfortable to some, but it benefits as a pain-relieving compression for others. In one RCT, 21 out of 28 patients (in the abdominal binder group) claimed no discomfort due to the adherence to the binder, while only 7 reported pain (Jiang et al., 2021). Seroma formation is considered one of the most recurrent complications post-breast surgery, be it a mastectomy, Modified Radical Mastectomy, or even reconstructive surgery (Agrawal et al., 2006; Carless & Henry, 2006; Kumar et al., 1995; Woodworth et al., 2000). Needle aspiration for seroma removal is a common cause of post-op clinical visits (Hashemi et al., 2004). This is why seroma reduction using different measures has become the goal of breast surgeons to make breast surgery possible with lesser pain and complications. Seroma accumulation causes the skin to stretch and causes it to sag as well, creating an even more discomforting and unpleasing appearance. Suppose the seroma formation continues for an extended period. In that case, it causes a delay in the healing of the wound, may cause skin flap necrosis, and be associated with surgical site infections and arm lymphedema (Kuroi et al., 2006). The pathophysiology or the cause of seroma is still vague (Ebner et al., 2014), but the leading cause, as per many RCTs and Meta-analyses, is considered dead space (Agrawal et al., 2006; de Rooij et al., 2020; Kuroi et al., 2006; Van Bastelaar et al., 2016; van Bemmel et al., 2011). One of the main reasons for this RCT is to study the results of applying pressure with the help of a thoracoabdominal https://journals.e-palli.com/home/index.php/ajcp Pa ge 17 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 binder to compress the dead space and reduce seroma production. Although the findings of this RCT are unclear and do not present extraordinary evidence in support of the usage of binders for the reduction of seroma formation, a couple of other larger studies do give positive outcomes analyzing the use of binders in seroma reduction, pain management and improvement in physical activity (lesser shoulder morbidities) (Rothman et al., 1966). One of the studies (Kontos et al., 2008) shows that pressure dressings (which can be modified into thoracoabdominal binders) make a significant difference in seroma production post-mastectomy. Two hundred patients were randomized into two groups; one of them was the PD (pressure dressing) group, while the other was non-PD. All the different surgical techniques and pre and postoperative supervision were kept similar. Their discoveries are in favor of PD as a viable, economical and simple to-apply technique for the decrease (a) of the time with drains in situ after MRM, (b) the number of patients producing seromas and (c) of the seroma aspirations. This might diminish further complexities, require clinical consideration, and cut expenses (Kontos et al., 2008). The use of such pressure dressings, binders and compressions of the wound has been discovered widely in other horizons of innovative surgery (P. K. Chowbey et al., 2000; K. A. LeBlanc, 2004). However, it is still in the early stages of breast surgery. More widespread, larger and more organized studies need to be executed to accumulate more and more verification and evidence to make the use of binders a common practice in the field of surgery (Rothman et al., 1966). Pain management post-surgery is one of the extensively recognized uses of binders in other fields of study. Once again, in breast surgery, the use is limited. Thus, the findings are ambiguous on whether it is beneficial or not. However, the mechanical support it provides to the wound decreases patients’ discomfort due to incisional pain. The pressure the binder applies supports the incision and even helps in wound healing to a small extent (Rettenmaier et al., 2017). Arm morbidity is one of the most inconvenient long- lasting complexities of breast cancer therapy and essentially affects the regular routines of breast cancer survivors (BCS). Despite its significance, persistent arm morbidity is moderately under-investigated (Kwan et al., 2002). Arm and shoulder morbidity reduces the quality of life of (BCS) greatly. Binders have shown slight improvement in shoulder movement in a few patients. This is also a reason to consider more research devoted to thoracoabdominal binder applications to determine their effectiveness, as references have been provided for inappreciable improvement in physical activity with the help of binders in this RCT. Cancer is fatal, so most patients also have mental health issues. Surgeries also bring out different levels of anxiety in most patients. This psychological stress worsens post- surgery due to the thought of any negative symptoms related to the operation (Rhodes et al., 2000). An RCT (Cheifetz et al., 2010) compared the pre and postoperative stress levels in patients divided into binder and no- binder groups to study the use of binders. The outcome suggested that the stress level remained the same in the binder group and rose significantly in the non-binder group. Similarly, a prospective controlled study (Daniel & Matheson, 1969) was held for a similar cause; it was detected that the psychological distress caused by coughing was exponentially reduced in the binder group compared to the others. The main reason behind the better emotional response in the binder group is the feeling of being held by the pressure of the binder wrapping around the incision. The pain of coughing post-surgery acts like trauma; thus, the compression provided by the binder eases that pain and helps reduce stress levels. It also facilitates the breathing process by covering the pain caused by the wound at the surgical site, and easy breathing also aids in the help of relieving depressive thoughts. As per the fore mentioned studies, binders help manage postoperative psychological distress; some patients feel extremely uncomfortable in the tightness of a thoracoabdominal binder. This discomfort is personal and non-scientific (Rothman et al., 1966). This study concludes that using binders causes no compromise to pulmonary function. CONCLUSION For the sake of actual implementation, the current investigation is uncertain as to the impact of thoracoabdominal binders on seroma development. Although there is faint evidence in favor of a slight reduction in the production of free fluid, the lack of concrete evidence and other factors like increased BMI etc., masking the impacts of compression by the binders make its effectiveness ambiguous. Insubstantial evidence is also mentioned in the binder groups’ positive pain management effects, emotional and physical distress, and moving capability. Thus, more large-scale studies and comparative meta-analyses need to be taken to justify using thoracoabdominal binders in patients post-mastectomy and MRM. B binders can help make breast surgery care post-surgery less painful and more economical for the patients, resulting in fewer clinic visits. LIMITATION One restriction of this study was puzzling due to neoadjuvant chemotherapy and axillary clearance. Axillary clearance and neoadjuvant chemotherapy have been demonstrated to expand the chances of patients undergoing seroma production. Another limitation may be the small size of the groups. Most trials require more cases to ensure the results are not constricted to a small environment or group of people. Also, the lack of versatility, as the entire trial is based in one country, may restrict the results to a certain environment. The pathophysiological reason for seroma formation is https://journals.e-palli.com/home/index.php/ajcp Pa ge 18 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 still ambiguous. Still, some surgeons might suggest that the BMI, other medical conditions and surgery at the same site before breast surgery may be a reason behind it. Moreover, in our data [table no.1], it can be seen that most patients suffer from conditions like diabetes mellitus and hypertension. In table no. 2, we can see the raised BMIs of some patients, which may cause hindrances in evaluating the accurate results. REFERENCE Agrawal, A., Ayantunde, A. A., & Cheung, K. L. (2006). Concepts of seroma formation and prevention in breast cancer surgery. ANZ Journal of surgery, 76(12), 1088-1095. Bourke, J., Balfour, T., Hardcastle, J., & Wilkins, J. (1976). A comparison between suction and corrugated drainage after simple mastectomy: a report of a controlled trial. Journal of British Surgery, 63(1), 67-69. Carless, P. A., & Henry, D. A. (2006). Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. Br J Surg, 93(7), 810-819. https://doi.org/10.1002/ bjs.5432 Cheifetz, O., Lucy, S. D., Overend, T. J., & Crowe, J. (2010). The effect of abdominal support on functional outcomes in patients following major abdominal surgery: a randomized controlled trial. Physiotherapy Canada, 62(3), 242-253. Chowbey, P., Sharma, A., Khullar, R., Mann, V., Baijal, M., & Vashistha, A. (2000). Laparoscopic ventral hernia repair. Journal of Laparoendoscopic & Advanced Surgical Techniques, 10(2), 79-84. Chowbey, P. K., Sharma, A., Khullar, R., Mann, V., Baijal, M., & Vashistha, A. (2000). Laparoscopic ventral hernia repair. J Laparoendosc Adv Surg Tech A, 10(2), 79-84. https://doi.org/10.1089/lap.2000.10.79 Daniel, W., & Matheson, N. (1969). Postoperative abdominal support. Journal of the Royal College of Surgeons of Edinburgh, 14(5), 294-296. de Rooij, L., van Kuijk, S. M., van Haaren, E. R., Janssen, A., Vissers, Y. L., Beets, G. L., & van Bastelaar, J. (2020). A single-center, randomized, non-inferiority study evaluating seroma formation after mastectomy combined with flap fixation with or without suction drainage: protocol for the Seroma reduction and drAin fRee mAstectomy (SARA) trial. BMC cancer, 20(1), 1-8. Droeser, R., Frey, D., Oertli, D., Kopelman, D., Peeters, M. B.-V., Giuliano, A., Dalberg, K., Kallam, R., & Nordmann, A. (2009). Volume-controlled vs no/ short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis. The Breast, 18(2), 109-114. Ebner, F., deGregorio, N., Vorwerk, E., Janni, W., Woeckel, A., & Varga, D. (2014). Should a drain be placed in early breast cancer surgery? Breast Care, 9(2), 116-116. Edwards, J. R., Peterson, K. D., Mu, Y., Banerjee, S., Allen- Bridson, K., Morrell, G., Dudeck, M. A., Pollock, D. A., & Horan, T. C. (2009). National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. American journal of infection control, 37(10), 783-805. Fagevik Olsén, M., Josefson, K., & Wiklund, M. (2009). Evaluation of abdominal binder after major upper gastrointestinal surgery. Advances in Physiotherapy, 11(2), 104-110. Hashemi, E., Kaviani, A., Najafi, M., Ebrahimi, M., Hooshmand, H., & Montazeri, A. (2004). Seroma formation after surgery for breast cancer. World journal of surgical oncology, 2, 1-5. Hematoma, toenail, gross. (2013). https://webpath.med. utah.edu/ATHHTML/ATH040.html Hoda, S. A., & Cheng, E. (2017). Robbins basic pathology. In: Oxford University Press US. Jiang, N., Hao, B., Huang, R., Rao, F., Wu, P., Li, Z., Song, C., Liu, Z., & Guo, T. (2021). The clinical effects of abdominal binder on abdominal surgery: a meta- analysis. Surgical Innovation, 28(1), 94-102. Jin, J., Schomisch, S., & Rosen, M. J. (2009). In vitro evaluation of the permeability of prosthetic meshes as the possible cause of postoperative seroma formation. Surgical Innovation, 16(2), 129-133. Kontos, M., Petrou, A., Prassas, E., Tsigris, C., Roy, P., Trafalis, D., Bastounis, E., & Karamanakos, P. (2008). Pressure dressing in breast surgery: is this the solution for seroma formation? J buon, 13(1), 65-67. Kopelman, D., Klemm, O., Bahous, H., Klein, R., Krausz, M., & Hashmonai, M. (1999). Postoperative suction drainage of the axilla: for how long? Prospective randomised trial. The European journal of surgery, 165(2), 117-120. Kumar, S., Lal, B., & Misra, M. C. (1995). Post-mastectomy seroma: a new look into the aetiology of an old problem. J R Coll Surg Edinb, 40(5), 292-294. Kurian, A. W., Lichtensztajn, D. Y., Keegan, T. H., Nelson, D. O., Clarke, C. A., & Gomez, S. L. (2014). Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. JAMA, 312(9), 902-914. Kuroi, K., Shimozuma, K., Taguchi, T., Imai, H., Yamashiro, H., Ohsumi, S., & Saito, S. (2006). Effect of mechanical closure of dead space on seroma formation after breast surgery. Breast Cancer, 13(3), 260-265. https://doi.org/10.2325/jbcs.13.260 Kwan, W., Jackson, J., Weir, L. M., Dingee, C., McGregor, G., & Olivotto, I. A. (2002). Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol, 20(20), 4242- 4248. https://doi.org/10.1200/jco.2002.09.018 Larson, C. M., Ratzer, E. R., Davis-Merritt, D., & Clark, J. R. (2009). The effect of abdominal binders on postoperative pulmonary function. Am Surg, 75(2), 169-171. Larson, C. M., Ratzer, E. R., Davis-Merritt, D., & Clark, J. R. (2009). The effect of abdominal binders on https://journals.e-palli.com/home/index.php/ajcp Pa ge 19 https://journals.e-palli.com/home/index.php/ajcp Am. J. Chem. Pharm. 2(2) 8-19, 2023 postoperative pulmonary function. The American Surgeon, 75(2), 169-171. LeBlanc, K. (2004). Laparoscopic incisional and ventral hernia repair: complications—how to avoid and handle. Hernia, 8(4), 323-331. LeBlanc, K. A. (2004). Laparoscopic incisional and ventral hernia repair: complications-how to avoid and handle. Hernia, 8(4), 323-331. https://doi.org/10.1007/ s10029-004-0250-5 Masià, J., Group, i. W., Salgarello, M., Cattelani, L., Parodi, P. C., Ribuffo, D., Onesti, M. G., Berna, G., Cawthorn, S. J., & Bozza, F. (2020). The largest multicentre data collection on prepectoral breast reconstruction: The iBAG study. Journal of surgical oncology, 122(5), 848-860. Masia, J., Pons, G., & Nardulli, M. L. (2016). Combined surgical treatment in breast cancer-related lymphedema. Journal of reconstructive microsurgery, 32(01), 016-027. Neumayer, L., Schifftner, T. L., Henderson, W. G., Khuri, S. F., & El-Tamer, M. (2007). Breast cancer surgery in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study. Journal of the American College of Surgeons, 204(6), 1235- 1241. Newman, L. A. (2014). Contralateral prophylactic mastectomy: is it a reasonable option? JAMA, 312(9), 895-897. Petrek, J., Peters, M., Cirrincione, C., & Thaler, H. (1992). A prospective randomized trial of single versus multiple drains in the axilla after lymphadenectomy. Surgery, gynecology & obstetrics, 175(5), 405-409. Pogson, C., Adwani, A., & Ebbs, S. (2003). Seroma following breast cancer surgery. European Journal of Surgical Oncology (EJSO), 29(9), 711-717. Prospero, E., Cavicchi, A., Bacelli, S., Barbadoro, P., Tantucci, L., & D’errico, M. (2006). Surveillance for surgical site infection after hospital discharge: a surgical procedure–specific perspective. Infection Control & Hospital Epidemiology, 27(12), 1313-1317. Rettenmaier, M. A., Micha, J. P., Lopez, K. L., Wilcox, A. M., & Goldstein, B. H. (2017). A Prospective, Observational Trial Assessing the Efficacy of Abdominal Compression in Reducing Laparoscopic- Induced Shoulder Pain. Surg Innov, 24(6), 552-556. https://doi.org/10.1177/1553350617718080 Rhodes, V. A., McDaniel, R. W., Homan, S. S., Johnson, M., & Madsen, R. (2000). An instrument to measure symptom experience. Symptom occurrence and symptom distress. Cancer Nurs, 23(1), 49-54. https:// doi.org/10.1097/00002820-200002000-00008 Rothman, J. P., Gunnarsson, U., & Bisgaard, T. (1966). Abdominal binders may reduce pain and improve physical function after major abdominal surgery-a systematic review. database, 2013. Salgarello, M. (2012). Breast Reconstruction: Current Techniques. BoD–Books on Demand. Srivastava, V., Basu, S., & Shukla, V. K. (2012). Seroma formation after breast cancer surgery: what we have learned in the last two decades. Journal of breast cancer, 15(4), 373-380. Tanner, L. (2014). Double mastectomy doesn’t boost survival for most. https://web.archive.org/ web/20140914001755/; http://bigstory.ap.org/article/ double-mastectomy-doesnt-boost-survival-most Terrell, G., & Singer, J. (1992). Axillary versus combined axillary and pectoral drainage after modified radical mastectomy. Surgery, gynecology & obstetrics, 175(5), 437- 440. Thoren, L. (1964). Z-plasty and suction drainage in radical mastectomy. Acta chirurgica Scandinavica, 128, 75-84. Van Bastelaar, J., Beckers, A., Snoeijs, M., Beets, G., & Vissers, Y. (2016). Flap fixation reduces seroma in patients undergoing mastectomy: a significant implication for clinical practice. World journal of surgical oncology, 14(1), 1-5. van Bemmel, A. J., van de Velde, C. J., Schmitz, R. F., & Liefers, G. J. (2011). Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol, 37(10), 829-835. https://doi. org/10.1016/j.ejso.2011.04.012 Vitug, A. F., & Newman, L. A. (2007). Complications in breast surgery. Surgical Clinics of North America, 87(2), 431-451. Whitfield, P., & Rainsbury, R. (1994). Suction versus siphon drainage after axillary surgery for breast cancer: a prospective randomized trial. Journal of British Surgery, 81(4), 547-547. Woodworth, P. A., McBoyle, M. F., Helmer, S. D., & Beamer, R. L. (2000). Seroma formation after breast cancer surgery: incidence and predicting factors. The American Surgeon, 66(5), 444-451. https://journals.e-palli.com/home/index.php/ajcp